Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein

被引:100
作者
Hooper, NM [1 ]
机构
[1] Univ Leeds, Proteolysis Res Grp, Sch Biochem & Microbiol, Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England
关键词
Alzheimer's disease; amyloid precursor protein; Creutzfeldt-Jakob disease; GPI anchor; lipid raft; pnon protein;
D O I
10.1042/BST0330335
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the amyloidogenic pathway, the APP (amyloid precursor protein) is proteolytically processed by the beta- and y-secretases to release the A beta (amyloid-beta) peptide that is neurotoxic and aggregates in the brains of patients suffering from Alzheimer's disease. in the non-amyloidogenic pathway, APP is cleaved by a-secretase within the A beta domain, precluding deposition of intact A beta peptide. The cellular form of the PrPc (prion protein) undergoes reactive oxygen Species-mediated beta-cleavage within the copper-binding octapeptide repeats or, alternatively, a-cleavage within the central hydrophobic neurotoxic domain. In addition, PrPc is shed from the membrane by the action of a zinc metalloprotease. Members of the ADAM (a disintegrin and metalloproteinase) family of zinc metalloproteases, notably ADAM10 and TACE (ADAM17) display a-secretase activity towards APP and appear to be responsible for the a-cleavage of PrPc. The amyloidogenic cleavage of APP by the beta- and y-secretases appears to occur preferentially in cholesterol-rich lipid rafts, while the conversion of PrPc into the infectious form PrPSc also appears to occur in these membrane domains.
引用
收藏
页码:335 / 338
页数:4
相关论文
共 49 条
[41]   Biomedicine - Toxic proteins in neurodegenerative disease [J].
Taylor, JP ;
Hardy, J ;
Fischbeck, KH .
SCIENCE, 2002, 296 (5575) :1991-1995
[42]  
VANOSTRAND WE, 1992, P NATL ACAD SCI USA, V89, P2552
[43]   Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons [J].
Vincent, B ;
Paitel, E ;
Frobert, Y ;
Lehmann, S ;
Grassi, J ;
Checler, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (45) :35612-35616
[44]  
Vincent B, 2001, J BIOL CHEM, V276, P37743
[45]   Cholesterol-dependent γ-secretase activity in buoyant cholesterol-rich membrane microdomains [J].
Wahrle, S ;
Das, P ;
Nyborg, AC ;
McLendon, C ;
Shoji, M ;
Kawarabayashi, T ;
Younkin, LH ;
Younkin, SG ;
Golde, TE .
NEUROBIOLOGY OF DISEASE, 2002, 9 (01) :11-23
[46]   The N-terminal region of the prion protein ectodomain contains a lipid raft targeting determinant [J].
Walmsley, AR ;
Zeng, F ;
Hooper, NM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37241-37248
[47]   Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors [J].
Wolozin, B ;
Kellman, W ;
Ruosseau, P ;
Celesia, GG ;
Siegel, G .
ARCHIVES OF NEUROLOGY, 2000, 57 (10) :1439-1443
[48]   A fluid connection:: Cholesterol and Aβ [J].
Wolozin, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5371-5373
[49]   Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation [J].
Yadavalli, R ;
Guttmann, RP ;
Seward, T ;
Centers, AP ;
Williamson, RA ;
Telling, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) :21948-21956